Stocks · Health care · Services-Medical Laboratories

VERACYTE, INC.

VCYT Clue Score73
United States Fiscal year ends December CIK 0001384101 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

By person

15 insiders · 52 transactions
30.8×

Marc Stapley holds 30.8 times base salary in stock. $21.61M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $50.00, the price Common Stock was last bought or sold at on the open market here, on 27 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Marc Stapley
Chief Executive Officer
—
$8.92M (5) scheduled
−$8.92M
432,073
0.5375%
$21.61M
+34.7%
Karin Eastham
Director
—
$1.85M (6) scheduled
−$1.85M
10,247
0.0127%
$512.40K
−69.2%
Rebecca Chambers
Chief Financial Officer
—
$1.62M (8) scheduled
−$1.62M
166,025
0.2065%
$8.30M
+18.8%
Jonathan Wygant
VP, Chief Accounting Officer
—
$1.54M (3) scheduled
−$1.54M
41,920
0.0521%
$2.10M
−15.1%
Annie McGuire
EVP, General Counsel
—
$1.46M (12) scheduled
−$1.46M
131,160
0.1632%
$6.56M
+38.1%
Jens Holstein
Director
—
$1.36M (6) scheduled
−$1.36M
27,471
0.0342%
$1.37M
−1.5%
John Leite
Global Chief Commercial Off
—
$1.25M (5) scheduled
−$1.25M
124,329
0.1547%
$6.22M
+63.2%
Phillip G. Febbo
Chief Scientific & Med Officer
—
$1.05M (3) scheduled
−$1.05M
133,048
0.1655%
$6.65M
+42.9%
Robert S Epstein
Director
—
$440.13K (1) scheduled
−$440.13K
57,718
0.0718%
$2.89M
+29.4%
Muna Bhanji
Director
—
$161.55K (2) scheduled
−$161.55K
40,854
0.0508%
$2.04M
+18.2%
Evan/ Fa Jones
Director
—
$55.58K (1) scheduled
−$55.58K
34,634
0.0431%
$1.73M
+0.8%
Eliav Barr
Director
—
—
—
56,461
0.0702%
$2.82M
+34.9%
Kevin Richard Haas
Chief Dev and Tech Officer
—
—
—
44,221
0.0550%
$2.21M
—
David Brent Shafer
Director
—
—
—
31,100
0.0387%
$1.56M
+88.4%
Thomas F. Miller
Director
—
—
—
31,100
0.0387%
$1.56M
+88.4%